INS and diabetes mellitus: By 2030, the number of individuals with diabetes worldwide is expected up to 552 million and most people with diabetes live in low-and middle-income countries where the diabetes drugs and insulin are often inaccessible or too expensive, and the local health-care systems do not have the capacity deal with personnel and financial issues.